W. Navarro

发表

Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.

K. van Besien, Stephanie J. Lee, S. Giralt, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Radiation Injury Treatment Network (RITN): Healthcare professionals preparing for a mass casualty radiological or nuclear incident

R. Hatchett, D. Weinstock, R. Hartzman, 2011, International journal of radiation biology.

Allogeneic hematopoietic cell transplant for HIV patients with hematologic malignancies: the BMT CTN-0903/AMC-080 trial.

J. Mellors, D. Porter, M. Horowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities.

K. van Besien, Stephanie J. Lee, M. Eapen, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.

L. Damon, W. Navarro, C. Linker, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Selection of adult unrelated hematopoietic stem cell donors: beyond HLA.

A. Madrigal, D. Confer, W. Navarro, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Preliminary treatment patterns and safety outcomes for non-small cell lung cancer (NSCLC) from ARIES, a bevacizumab treatment observational cohort study (OCS)

T. Lynch, Priya Kumar, S. Teng, 2008 .

Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.

H. Rugo, S. Tolaney, L. Damon, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-Dose Etoposide, Thiotepa, and Dose-Adjusted Carboplatin (TVCa) With Autologous Hematopoietic Stem Cell Rescue as Treatment of Relapsed or Refractory Germ Cell Cancer

H. Rugo, E. Small, L. Damon, 2005, American journal of clinical oncology.

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial

C. Hofmeister, A. Krishnan, W. Wachsman, 2021, Frontiers in Immunology.

Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report.

M. Perales, M. Litzow, N. Majhail, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.

J. Varni, W. Tse, M. Horowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

P. Hari, J. Varni, W. Tse, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors

D. Hyman, D. Rasco, K. Cadoo, 2019, Clinical Cancer Research.

Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (

U. Popat, S. Devine, R. Ambinder, 2014 .

Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.

A. Badley, S. Hashmi, M. Litzow, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor.

K. Blum, B. Christian, Weiqiang Zhao, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.

A. Krishnan, G. Lozanski, M. Horowitz, 2016, Blood.

High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia.

P. Varosy, L. Damon, W. Navarro, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

J. Wingard, D. Stroncek, B. Shaw, 2013, Blood.

Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.

B. Shaw, B. Logan, M. Pulsipher, 2014, Blood.

Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.

D. Niederwieser, Y. Kodera, A. Buser, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Results of a prospective multicentre myeloablative double‐unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia

S. Devine, B. Logan, T. Kindwall‐Keller, 2015, British journal of haematology.

Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services

S. Spellman, E. Waller, W. Harris, 2014, Transfusion.

National marrow donor program session: donor issues.

G. Switzer, M. Pulsipher, W. Navarro, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

L. Kaplan, W. Navarro, 2006, Blood.

P. Hari, W. Tse, M. Horowitz, 2018, Haematologica.

PF719 CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+PTLD WHO FAIL FIRST-LINE RITUXIMAB OR RITUXIMAB PLUS CHEMOTHERAPY: AN ANALYSIS OF GERMAN PTLD REGISTRY

X. Li, W. Navarro, H. Zimmermann, 2019, HemaSphere.

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

J. Vose, K. van Besien, H. Lazarus, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B ffect of Body Mass Index on Mortality of Patients ith Lymphoma Undergoing Autologous ematopoietic Cell Transplantation

J. Vose, H. Lazarus, F. Loberiza, 2006 .

Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.

J. Vose, Sonali M. Smith, P. Hari, 2008, Biology of Blood and Marrow Transplantation.

Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era.

R. Hartzman, G. Switzer, S. Devine, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.

M. Pasquini, K. Ballen, J. Liesveld, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder

S. Nikiforow, R. Baiocchi, K. Mahadeo, 2017 .

Allogeneic hematopoietic cell transplant (alloHCT) for hematologic malignancies in human immunodeficiency virus infected (HIV) patients (pts): Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0903)/AIDS Malignancy Consortium (AMC-080) trial.

J. Mellors, M. Horowitz, U. Popat, 2017 .

The Impact of Obesity on Stem Cell Transplant

F. Loberiza, W. Navarro, 2012 .

Phase I/II Study of Bortezomib in Combination with Liposomal Doxorubicin and Melphalan in Relapsed or Refractory Multiple Myeloma.

A. Chari, L. Kaplan, L. Damon, 2005 .

Autologous stem cell transplantation for acute myeloid leukemia in first remission.

H. Rugo, L. Damon, P. Crilley, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Obesity and lymphoma therapy: not a bad combination after all

F. Loberiza, W. Navarro, 2010, Leukemia & lymphoma.

Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001–2003

J. Goedert, M. Lederman, J. Goedert, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

J. Wingard, D. Stroncek, B. Shaw, 2013, Blood.

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults

M. Pasquini, K. Ballen, J. Liesveld, 2008 .